The Epilepsy Foundation of Greater Chicago is offering our college scholarships again for the 2015/2016 academic school year – apply for one today!
LATEST EFGC NEWS
The marijuana seeds can soon be planted. In a move that surprised advocates of the medical marijuana program, Gov. Bruce Rauner’s administration on Monday announced it would issue most of the coveted licenses to grow and sell the medical product.
Carolyn and Mike Burkhead of downstate Maryville do not know what they are going to do. Their 3-year-old daughter Mira has a form of epilepsy that subjects her to severe, debilitating seizures. Her parents have tried nine different medications to treat Mira’s illness, but so far none have worked. The Burkheads’ last hope is cannabidiol, or CBD, a key ingredient in cannabis plants that does not have psycho-active properties, but has shown promise in the treatment of epilepsy. They had hoped that legal CBD, under the pilot medical marijuana program that began Jan. 1, would by available by now. So far it isn’t.
‘Microlesions’ in epilepsy discovered by novel technique in a study conducted by newly elected EFGC Board Member, Jeffery Loeb, MD
Using an innovative technique combining genetic analysis and mathematical modeling with some basic sleuthing, researchers have identified previously undescribed microlesions in brain tissue from epileptic patients. The millimeter-sized abnormalities may explain why areas of the brain that appear normal can produce severe seizures in many children and adults with epilepsy.
Lisa Thomas is hoping there is a cure for the cost to cure. Thomas, whose 16-year-old son Ryan has epilepsy that causes seizures, takes less than two months to blow past the family’s annual $3,000 deductible because of the high copay costs for her son’s medication. She said it’s not unusual to hit the $10,000 out-of-pocket maximum in copay expenses in six months.
In advance of the American Epilepsy Society’s (AES) Annual Meeting in December, the organization has offered highlights of groundbreaking research being studied at a number of institutions regarding the effectiveness of cannibidiol (CBD) and its derivatives as a viable treatment for people with epilepsy.
333 Patient Groups Join Together to Ask HHS Secretary Burwell to Reduce Barriers to Care in Qualified Health Plans
Three-hundred-and-thirty-three patient groups from around the country have signed onto a letter to Secretary of Health and Human Services (HHS) Sylvia Mathews Burwell calling for immediate measures to reduce barriers to care for patients who have purchased policies through the Health Insurance Marketplace (the “exchanges”). The letter comes as some patients with chronic conditions have faced difficulty accessing crucial medications and other health services they need in some Qualified Health Plans, and as HHS is reviewing plans for 2015.